Patent ID: 9315438
Filing Date: 2016-04-19
CPC Classification: A61K,C07C,C07D

Claim Text:
1. A stereoisomeric compound of the compound represented by formula (I) or a pharmaceutically acceptable salt thereof, wherein said stereoisomeric compound is selected from the compound represented by formula (II) and the compound represented by formula (III): which is (2S,3R,4R,5S,6R)-2-(3-(4-(((1R,3s,5S)-bicyclo[3.1.0]hexan-3-yl)oxy)benzyl)-4-chlorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, which is (2S,3R,4R,5S,6R)-2-(3-(4-(((1R,3r,5S)-bicyclo[3.1.0]hexan-3-yl)oxy)benzyl)-4-chlorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol.